87,99 €
Rutter's Child and Adolescent Psychiatry is the leading textbook in its field.
Both interdisciplinary and international, it provides a coherent appraisal of the current state of the field to help researchers, trainees and practicing clinicians in their daily work. Integrating science and clinical practice, it is a comprehensive reference for all aspects of child and adolescent psychiatry.
New to this full color edition are expanded coverage on classification, including the newly revised Diagnostic and Statistical Manual of Mental Disorders (DSM-5), and new chapters on systems neuroscience, relationship-based treatments, resilience, global psychiatry, and infant mental health.
From an international team of expert editors and contributors, this sixth edition is essential reading for all professionals working and learning in the fields of child and adolescent mental health and developmental psychopathology as well as for clinicians working in primary care and pediatric settings.
Michael Rutter has contributed a number of new chapters and a Foreword for this edition: "I greatly welcome this new edition as providing both a continuity with the past and a substantial new look."
—Professor Sir Michael Rutter, extract from Foreword.
Reviews of previous editions:
"This book is by far the best textbook of Child & Adolescent Psychiatry written to date."
—Dr Judith Rapoport, NIH
"The editors and the authors are to be congratulated for providing us with such a high standard for a textbook on modern child psychiatry. I strongly recommend this book to every child psychiatrist who wants a reliable, up-to-date, comprehensive, informative and very useful textbook. To my mind this is the best book of its kind available today."
—Journal of Child Psychology and Psychiatry
Sie lesen das E-Book in den Legimi-Apps auf:
Seitenzahl: 4398
Veröffentlichungsjahr: 2015
Cover
Title Page
Copyright
List of contributors
Foreword
Preface
Part I : Conceptual issues and research approaches
A: Developmental psychopathology
Chapter 1: Development and psychopathology: a life course perspective
Introduction
Methodological considerations
Childhood–adulthood continuities
Long-term effects of early experience
Conclusions
References
Chapter 2: Diagnosis, diagnostic formulations, and classification
Introduction
Definition
Clinical and research classifications
Biomarkers and neural signatures
Dimensions and categories
The supposed separateness of syndromes
Validation of diagnostic categories
“Lumping” or “splitting”
Threshold for diagnosis
Separate classifications in different countries
Staging or severity of disorders
References
Chapter 3: Neurodevelopmental disorders
The classification of neurodevelopmental disorders
Concepts of maturational lag and of plateaus in developmental progress
Concept of comorbidity and patterns of co-occurrence within the group of neurodevelopmental disorders
The co-occurrence of different neurodevelopmental disorders due to shared risks and biological characteristics
Sex differences
Does neurodevelopmental impairment have the same meaning in all disorders?
Clinical value of neurodevelopmental impairment concepts
Acknowledgments
References
Chapter 4: Conceptual issues and empirical challenges in the disruptive behavior disorders
The scope of this chapter
What is the phenotype?
The starting point: well-replicated findings
What do we need to explain?
Unraveling risks for disruptive behavior problems
Peer influences
Sex differences
“Comorbidity”
Adolescent onset of disruptive and antisocial behaviors
Conclusions
References
Chapter 5: Emotion, emotion regulation and emotional disorders: conceptual issues for clinicians and neuroscientists
Terms and definitions
Basic emotions
Emotion regulation
Emotion and development
Disorders of emotion and emotion regulation: boundaries to normality, relation to basic science, and other challenges
Emotions and treatment
Conclusion and outlook
References
Chapter 6: Attachment: normal development, individual differences, and associations with experience
Historical context of the development of attachment theory
Infant attachment quality
Individual differences
Links between infant attachment and later outcomes
Assessments of attachment beyond infancy
Attachment and neurobiology
Attachment among fathers
Attachment among atypical populations
Attachment and interventions
Future directions
Conclusions
References
Chapter 7: Infant/early years mental health
Introduction
Risk and protective factors
Special features in assessing infants
Common problems versus pathways to psychopathology
Special features of interventions in infancy
Conclusion
References
Chapter 8: Temperament: individual differences in reactivity and regulation as antecedent to personality
Introduction
Definitions and conceptual distinctions between temperament and personality
Approaches to the study of temperament
Assessment of temperament
Genetic origins of temperament
The temperament of behavioral inhibition
Temperament and adjustment
Behavioral inhibition: temperament or psychopathology?
Future directions in temperament research
Final comments
References
B: Neurobiology
Chapter 9: Neurobiological perspectives on developmental psychopathology
Introduction
Key issues in developmental neurobiology
Human structural brain development
Key features of postnatal development
Oscillating rhythms
Resting activity and network connectivity
Determinants of cortical specialization
Human functional brain development
Atypical human neurodevelopment
Risk
Resilience
Future directions
Definitions
Acknowledgements
References
Chapter 10: Systems neuroscience
Introduction
Child psychiatry and systems neuroscience
Cognitive control
Fear
Attachment and affiliation
Brain development
Conclusion
References
Chapter 11: Neuroimaging in child psychiatry
Introduction
Overview of neuroimaging techniques
Analysis and interpretation of imaging data
Conclusions
References
C: Epidemiology, interventions and services
Chapter 12: Using natural experiments and animal models to study causal hypotheses in relation to child mental health problems
Introduction
Why natural experiments are useful
Natural experiment designs used to test causal hypotheses on environmental risks and that control for genetic contribution
Natural experiment designs that aim to remove or reduce selection or allocation bias in defined populations
Statistical methods to reduce selection biases and confounders
Experimental manipulation in humans
Animal models to test environmental influences
Animal models to study the causal effects of genetic risks
Behavior-based animal models to study causal risks in relation to multifactorial psychiatric disorders
A wide variety of animal species can inform causal research in psychopathology
Conclusions
References
Chapter 13: Using epidemiology to plan, organize, and evaluate services for children and adolescents with mental health problems
Introduction
Why bother?
Overview of key methodological issues
Interpreting epidemiological data
What is need?
What can epidemiology tell us about levels of need?
What can epidemiology tell us about planning to meet need?
Service use now
What factors predict access?
Using epidemiology to determine organization
Using epidemiology to determine funding arrangements
Using epidemiological data to understand outcomes of treatment for teams and services
Conclusion and further directions
Acknowledgments
References
Chapter 14: Evaluating interventions
Introduction
The fundamental principles
Alternatives to RCTS?
Effect sizes. Not
P
-values
Exploratory activities, pilot studies, and RCTS
Formulating the hypothesis
Designing the RCT
RCT execution/fidelity
Primary analysis and presentation of results
Moving the frontiers: exploration of RCT data
Completing the cycle: meta-analysis
Discussion
References
Chapter 15: What clinicians need to know about statistical issues and methods
Common misunderstandings, study design, multiple testing, meta-analysis and the natural history of “findings”
Confounding, selection and randomization
Adjustment for measured confounders: regression and the generalized linear model
Mechanisms and statistical interactions and effects scales
Longitudinal data analysis
Measurement error, latent variables and growth models
Causal analysis
Missing data
Screening, diagnosis and misclassification
Reporting results
Conclusions
References
Chapter 16: Global psychiatry
Introduction
Context heterogeneity
Methods in global child and adolescent psychiatric epidemiology
Challenges and opportunities
Future perspectives
References
Chapter 17: Prevention of mental disorders and promotion of competence
Epidemiology and the rationale for preventive interventions
The role of developmental theory in the prevention of MEBDs
Defining prevention
Empirical advances in prevention research with children and families
Key issues in current prevention research
Dissemination, implementation and sustainability; Type 2 questions
Conclusion
References
Chapter 18: Health economics
Introduction
Costs in childhood
Costs continuing into adulthood
Cost-offset considerations
Exploring cost-effectiveness
Conclusion
References
Chapter 19: Legal issues in the care and treatment of children with mental health problems
The universality of human rights
The different roles of the mental health professional
Intervening against the parents
Intervening against the child
Expert witnesses
Conclusion
References
Chapter 20: Children's testimony: a scientific framework for evaluating the reliability of children's statements
Outline of present case involving allegations of sexual abuse
Research findings/major principles
Scientific analysis of the facts of the case
References
Chapter 21: Residential and foster care
Introduction
Residential care
Foster care
Assessment
Intervention
Conclusions
Acknowledgments
References
Chapter 22: Adoption
Contemporary trends in adoptive family formation
Alternatives for individuals and families who want to adopt
Gay and lesbian adoption
Opening the birth records: search for birth parents (including ART donors)
Outcomes of adoption
Selection, preparation, and assessment
Postadoption services
Conclusions and future directions
References
Part II: Influences on psychopathology
Chapter 23: Biology of environmental effects
Introduction
Prenatal experiences
Postnatal maltreatment
Institutional deprivation
Social disadvantage
Enrichment and deprivation studies
Experience-expectant effects
Pollutants
Traumatic brain injury
Biological effects of different therapeutic interventions
Gene–environment interaction (G × E)
Overall conclusions
References
Chapter 24: Genetics
Introduction
DNA, genes and chromosomes
Genetic variation and its detection
Relating Genes to Behaviors
Approaches to gene discovery
Summary: recent findings and changing conceptions
References
Chapter 25: Epigenetics and the developmental origins of vulnerability for mental disorders
Parental influences
Epigenetics
Maternal regulation of stress reactivity in the offspring
The human early environment and DNA methylation
Tissue specificity: DNA methylation in blood and brain
The molecular definition of gene × environment interaction
Methodological considerations in studies of epigenetics
Summary and concluding remarks
References
Chapter 26: Psychosocial adversity
Introduction
Conceptual issues in the effects of psychosocial adversity on children
Empirical findings on distal risk factors
Empirical findings on proximal risk factors: development in the context of close relationships
Summary of findings related to psychosocial adversity causing child psychopathology
Directions for future research
References
Chapter 27: Resilience: concepts, findings, and clinical implications
Testing for environmental mediation of risks
Types of features associated with resilience
Clinical implications
Conclusions
References
Chapter 28: Impact of parental psychiatric disorder and physical illness
Intergenerational transmission of psychiatric disorder: a conceptual and theoretical overview
Intergenerational transmission of psychopathology: one size does not fit all
The mechanics of mechanism: mediators versus moderators in clinical research
Parental psychiatric disorders
Psychiatric disorders in fathers
Parental physical disorders
Clinical implications
Summary
References
Chapter 29: Child maltreatment
Safeguarding children: a pressing global challenge
Definitions: maltreatment types
Epidemiology
Factors associated with occurrence of maltreatment
Consequences of maltreatment
Recognizing child maltreatment
Responding to child maltreatment
Interventions
Prevention of maltreatment occurrence
Future directions
References
Chapter 30: Child sexual abuse
Introduction
Definitions
Cultural aspects
Demographics
The nature and circumstances of the abuse
Epidemiology
Risk and maintaining factors for child sexual abuse
Effects of child sexual abuse
Suspicion, recognition, investigation, validation, and protection
Therapeutic work
Conclusions
References
Chapter 31: Brain disorders and psychopathology
Brain damage?
Birth damage
Brain dysfunction increases the risk of child psychiatric disorders
At risk for which psychiatric disorders?
How do neurological and non neurological risk factors interact?
What are the mediating links?
The psychiatric consequences of specific brain disorders
Treatment of psychiatric problems in children with brain disorders
References
Part III: Approaching the clinical encounter
A: The clinical assessment
Chapter 32: Clinical assessment and diagnostic formulation
Introduction
Initial questions regarding referral
Observations of the family
Basic elements in the diagnostic clinical assessment
Standardization of clinical assessment
Presence/absence of clinically significant psychopathology
Diagnostic formulation: integration and synthesis
Psychoeducation
Treatment planning
Approaches to assessment and treatment planning across the globe
Conclusions
References
Chapter 33: Use of structured interviews, rating scales, and observational methods in clinical settings
Introduction
Selecting measures
Interviews
Scales
Observations
Implementing standardized assessments in clinical settings
Conclusion
References
Chapter 34: Psychological assessment in the clinical context
Introduction
Psychological assessment within the broader context
Informal and semi-formal clinical assessments
Formal psychometric assessment
What to report and how
Using psychological assessments to inform intervention
Conclusions
References
Chapter 35: Physical examination and medical investigation
Introduction
The medical history
The physical examination
Laboratory investigation
An example: the evaluation of psychosis
Summary
References
B: Considering and selecting available treatments
Chapter 36: Psychological interventions: overview and critical issues for the field
Studying the effects of youth psychotherapy: methods and findings
Investigating the strength, causes, and conditions of effective treatment
Adapting and testing psychotherapies for diverse populations
Putting science into practice: EBPs and the clinical practice of youth mental health care
Strategies for strengthening youth psychotherapies and intervention science
Summary and concluding comment
References
Chapter 37: Parenting programs
Introduction
Programs for children with conduct problems
Programs for infants
Father involvement in parenting programs
Application of programs to specific populations
What makes parenting programs work?
Implementation and dissemination
Prevention
Conclusions
References
Chapter 38: Cognitive-behavioral therapy, behavioral therapy, and related treatments in children
Understanding cognitive-behavioral therapy (CBT)
Empirically-supported CBTs and BTs for youth
Common treatment components
Flexible adaptations of CBT
CBT related therapies
Future directions
Acknowledgment
References
Chapter 39: Family interventions
Family interventions in the broader context of other psychological treatments
The role of the family therapist in the multidisciplinary team
Theoretical considerations informing work with families
A conceptual framework for working with families
Practical issues and techniques of family interventions
Contraindications for family interventions and/or indications to proceed with special care
Research evidence informing family therapy practice
Conclusions
References
Chapter 40: Relationship-based treatments
Introduction
Treatments targeted at early relationships
Therapist–patient relationship as a mode of treatment
Psychotherapeutic treatments for children and adolescents
Implementation science
Global health
References
Chapter 41: Educational interventions for children's learning difficulties
Conceptual and methodological issues
Dyslexia and decoding impairments
Reading comprehension impairment
Specific language impairment
Summary: interventions for oral language impairments in children
Mathematics disorder
The effectiveness of educational interventions for children with general learning difficulties
The effectiveness of interventions targeting general cognitive functions
Conclusions and future directions for clinical practice and research
References
Chapter 42: School-based mental health interventions
Introduction
Addressing mental health problems at schools
Strengths and weaknesses of school-based interventions
Methods of delivering interventions at school
Staff delivering interventions
Types of intervention
School-based mental health in practice
Conclusions
References
Chapter 43: Pharmacological, medically-led and related treatments
Introduction and regulation of psychoactive drugs
Place of medication in therapeutic planning
Prescribing: evidence and practice
Research and future developments
References
C: Contexts of the clinical encounter and specific clinical situations
Chapter 44: Refugee, asylum-seeking and internally displaced children and adolescents
Introduction
Prevalence of psychiatric disorder
Risk and resilience in young refugees
Interventions
Course and long-term outcomes for young refugees
Conclusions
References
Chapter 45: Pediatric consultation and psychiatric aspects of somatic disease
Introduction
History
Consultation service models
“Liaison” care
Approach to consultation requests
The consultation
Reasons for consultation: primary psychiatric illnesses
Reasons for consultation: emergency consultations
Reasons for consultation: psychological distress in the medically ill children
Conclusion
References
Chapter 46: Mental health and resilience in children and adolescents affected by HIV/AIDS
The global impact of HIV/AIDS on children and adolescents
The effects of HIV/AIDS on the social ecology, child development, and mental health
Brief overview of HIV and child health
Modes of HIV transmission in children and adolescents
HIV and its neurological impact in children and adolescents
HIV and psychopathology
Mental health and ART adherence
Mental health treatment for children and adolescents with HIV
Resilience in children, adolescents, and families affected by HIV/AIDS
Disclosure
Implications for intervention research and clinical settings
Group interventions for children and adolescents living with HIV
Family-based interventions
Economic strengthening interventions
Community level interventions addressing stigma
Recommendations
References
Chapter 47: Children with specific sensory impairments
Visual impairment
Hearing impairment
Professional approaches for management and care
References
Chapter 48: Assessment and treatment in nonspecialist community health care settings
Introduction
Generalist primary health settings
Core roles of primary health care for child and adolescent mental health
Child and adolescent mental health problems in nonspecialist primary care settings
Identification of mental health problems in primary care
Delivering interventions, partnerships, and coordinated care
Prevention and early intervention
Building capacity in the front line
Conclusions and further developments
References
Chapter 49: Forensic psychiatry
Introduction
Juvenile justice systems: a global perspective
A developmental understanding of juvenile delinquency
The mental health of juvenile offenders
Forensic psychiatric assessment of juveniles
Interventions
Professional considerations
Conclusions
Acknowledgments
References
Chapter 50: Provision of intensive treatment: intensive outreach, day units, and in-patient units
Introduction
Day programs (partial hospitalization)
Inpatient services
Final conclusions
References
Part IV : Clinical syndromes: neurodevelopmental, emotional, behavioral, somatic/body-brain
A: Neurodevelopmental
Chapter 51: Autism spectrum disorder
Overview
Clinical characteristics of ASD
The history of diagnosis and classification
Epidemiology
Cognitive and emotional processes
Longitudinal outcome
Risk factors and possible aetiologic mechanisms
Neurotransmitters and neuromodulators
Neuropathology findings and post mortem studies
Brain imaging
Assessment
Treatments
Future developments and necessary research
Acknowledgments
References
Chapter 52: Disorders of speech, language, and communication
Introduction
General principles of assessment
Differential diagnosis of speech disorders
Language disorder
Social (pragmatic) communication disorders
Intervention
Conclusions
Acknowledgments
References
Chapter 53: Disorders of reading, mathematical and motor development
Definitions and diagnosis
Disorders of reading and writing
Causal models and risk factors
Sensory impairments in dyslexia
Language delays and difficulties as precursors of reading difficulties
Attentional difficulties and reading disorders
Etiology of reading difficulties
Brain bases of dyslexia
Social and environmental influences on reading development and disorder
Summary
Problems of numeracy
The typical development of number skills and arithmetic
Definition, classification, and prevalence of mathematical difficulties
The behavioral profile of children with mathematics disorder
Cognitive explanations of arithmetic difficulties
Summary
Etiology of mathematics disorder
Developmental coordination disorder (DCD)
Explanations of developmental coordination disorder
Etiology
Longitudinal outcome of learning disorders
Cognitive and educational outcomes
Psychosocial and mental health outcomes
Other learning difficulties
Clinical implications
Communicating findings
Management of specific learning disorders
Conclusions and future directions
References
Chapter 54: Intellectual disability
Terminology and classification
Epidemiology of intellectual disability
Causes of intellectual disability
Assessment and diagnosis of intellectual disability
Longitudinal course of intellectual disability
Behavioral phenotypes
Mental disorders in children and adolescents with intellectual disability
Risk factors for psychiatric disorders in ID
Assessment of psychiatric disorders in people with ID
Intervention
Mental health services for children and adolescents with ID
Special issues in mental health and ID
Future developments and necessary research
References
Chapter 55: ADHD and hyperkinetic disorder
Diagnosis
Clinical assessment
Epidemiology
Risk factors
Pathogenesis
Longitudinal course
Treatment
References
Chapter 56: Tic disorders
Introduction
Phemonenology of tics and diagnosis of tic disorders
Epidemiology
Clinical course
Clinical assessment
Risk factors
Pathophysiology
Treatment
Future directions
Acknowledgments
References
Chapter 57: Schizophrenia and psychosis
Introduction
Clinical features
The clinical phases of schizophrenia
Diagnosis of schizophrenia in childhood and adolescence
Course and outcome
Epidemiology
Genetic risk factors
Environmental risk factors
Psychosocial risks
Gene–environment interactions
Neurobiology
Neuropsychology of schizophrenia
Assessment
Treatment approaches
Conclusions
References
B: Emotional
Chapter 58: Disorders of attachment and social engagement related to deprivation
Definitions
Development of attachment
Attachment classifications and psychopathology
Historical considerations
Clinical disorders of attachment: the phenotypes
Differential diagnosis
Prevalence
Etiology
Course of the disorders
Clinical assessment
Interventions
Conclusions
References
Chapter 59: Post traumatic stress disorder
Characteristics and diagnosis of the condition
Manifestations of stress reactions in children and adolescents
Developmental aspects
Cultural issues
Impact of disorder on functioning
Differential diagnosis
Assessment
Epidemiology
Longitudinal outcome
Risk factors
Pathological risk processes
Treatment
Conclusions and recommendations
References
Chapter 60: Anxiety disorders
Introduction
Diagnosis
Assessment
Epidemiology
Longitudinal outcome
Risk factors
Pathophysiology
Treatment
Summary
References
Chapter 61: Obsessive compulsive disorder
Definition: the concept and current issues
Epidemiology
Diagnostic issues
The importance of informant history
Issues with DSM-5 diagnosis
Obsessive compulsive spectrum disorders
Unique childhood onset subtypes
Clinical presentation
Course and natural history
Associated disorders
Case illustrations
The differential diagnosis: distinguishing OCD from other disorders
Theories of etiology
Biological factors
Treatment approaches
Conclusions
References
Chapter 62: Bipolar disorder in childhood
Introduction
Characteristics and diagnosis of the condition
Assessment
Epidemiology
Longitudinal outcome
Risk factors
Pathophysiology
Treatment
Future developments and necessary research
References
Chapter 63: Depressive disorders in childhood and adolescence
Clinical picture
Descriptive epidemiology
Course and outcome
Models of depression
Neurobiology of depression
Treatment
Clinical approach to depressed youth
Future clinical and research challenges
References
Chapter 64: Suicidal behavior and self-harm
Definitions of terms
Population prevalence of suicide, suicidal ideation, and self-harm
Risk factors associated with suicidal phenomena in young people
Psychiatric disorders associated with self-harm and suicide
Exposure to suicide and self-harm in the media, the Internet, and music
Availability of means for self-harm/suicide
Outcome following self-harm
Impact of suicide on peers, school and relatives
Clinical assessment
Treatments for adolescents who have self-harmed
Treatments for adolescents with specific psychiatric disorders
Issues of access to treatment and engagement in treatment
Prevention of self-harm and suicide by children and adolescents
Conclusions, future clinical and research directions
Acknowledgment
References
C: Behavioral
Chapter 65: Oppositional and conduct disorders
Introduction
Classification
Epidemiology
Etiology
School effects
Poverty
Neighborhood influences
Assessment, diagnosis, and formulation
Intervention
Conclusions
References
Chapter 66: Substance-related and addictive disorders
Introduction
Definitions, comparative nosology
Epidemiology
Genetic and environmental risk factors
Longitudinal course
Prevention
Screening, assessment
Treatment
Non-substance “behavioral addictions”
Future developments and necessary research
Acknowledgments
References
Chapter 67: Disorders of personality
Why is something like the concept of personality disorders needed?
Current conceptualizations of personality disorder and diagnostic and statistical manual (DSM) IV and 5
Key questions
Validation
Differentiation among personality disorders
Utility of the personality disorder concept in childhood and adolescence
Specific personality disorders
The application of personality disorders research in clinical practice
Conclusions
References
Chapter 68: Developmental risk for psychopathy
Introduction: characteristics and diagnosis of psychopathy
Assessment
Epidemiology and longitudinal outcomes
Risk factors
Neurocognitive findings
Treatment implications
Future developments and necessary research
Conclusions
Acknowledgements
References
D: Somatic/body-brain
Chapter 69: Gender dysphoria and paraphilic sexual disorders
Introduction
Gender dysphoria (GD)
Paraphilic sexual disorders
Summary and conclusions
References
Chapter 70: Sleep interventions: a developmental perspective
Introduction
Epidemiology
Longitudinal outcome and sleep as a risk factor
Assessment
Interventions for common sleep disorders of childhood and adolescence
Technology use
Conclusions and future directions
References
Chapter 71: Feeding and eating disorders
Introduction
Diagnosis and presentation
Epidemiology
Risk factors and etiology
Assessment
Treatment
Outcome
Conclusion
References
Chapter 72: Somatoform and related disorders
Characteristics of the disorders and classification
Clinical presentations, assessment and diagnosis
Epidemiology
Longitudinal outcome and long-term adjustment
Risk factors
Pathological risk processes
Assessment. Treatment and treatment setting
Future developments and necessary research
References
Index
End User License Agreement
ix
x
xi
xii
xiii
xiv
xv
xvi
xvii
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
1001
1002
1003
1004
1005
1006
1007
1008
1009
1010
1011
1012
1013
1014
1015
1016
1017
1018
1019
1020
1021
1022
1023
1024
1025
1026
1027
1028
1029
1030
1031
1032
1033
1034
1035
1036
1037
1038
1039
1040
1041
1042
1043
1044
1045
1046
1047
1048
1049
1050
1051
1052
1053
1054
1
3
105
143
285
403
405
461
573
661
663
793
911
981
1055
1056
1057
1058
1059
1060
1061
1062
1063
1064
1065
1066
1067
1068
1069
1070
1071
1072
1073
1074
1075
1076
1077
Cover
Table of Contents
Foreword
Preface
Part I : Conceptual issues and research approaches
Begin Reading
Chapter 3: Neurodevelopmental disorders
Figure 3.1
A schematic Figure illustrating potential contributions to the overlap between different neurodevelopmental disorders.
Clinical phenotypes as conceptualized diagnostically overlap with each other. Variation in clinical phenotypes can be conceptualized at a different phenotypic level involving “neural and biological characteristics” (e.g., variation in brain structure and function). These phenotypes can be influenced by genetic and environmental risk factors and stochastic factors that include random occurrences or insults. Epigenetic changes (see Chapter 25) involve biological modifications of the genome that can reflect early environmental exposures, DNA sequence and stochastic factors and can in turn be later modified by later experiences shaped by individual phenotype.
Chapter 4: Conceptual issues and empirical challenges in the disruptive behavior disorders
Figure 4.1 Summary of possible pathways to disruptive behavior problems.
Chapter 5: Emotion, emotion regulation and emotional disorders: conceptual issues for clinicians and neuroscientists
Figure 5.1 The findings of Lench
et al.
's (2011) pairwise comparisons between emotions can be accounted for by differences in valence and arousal between emotions. Emotion categories are depicted in a circumplex structure based on their average degree of valence and arousal. Average effect sizes for each paired comparison are listed. The largest effect sizes occur for cross-valence comparisons, followed by cross-arousal comparisons. The smallest effect size observed is between anger and anxiety, emotions of the same valence and arousal.
Figure 5.2 Distribution and density of output projections between the prefrontal cortex and the amygdala in the primate brain. Top row, medial aspect of the frontal lobe, middle row, lateral aspect of the frontal lobe, bottom row, orbitofrontal surface of the frontal lobe. AMY = amygdala.
Chapter 6: Attachment: normal development, individual differences, and associations with experience
Figure 6.1 Conceptual overview of the predictors of individual differences in parent–child attachment quality and links to later outcomes.
Chapter 7: Infant/early years mental health
Figure 7.1 Transactional relations between self-regulation and other-regulation (Sameroff, 2010).
Figure 7.2 Lausanne Trilogue play situation.
Figure 7.3 WAIMH affiliates 2013.
Chapter 8: Temperament: individual differences in reactivity and regulation as antecedent to personality
Figure 8.1 Three approaches to identifying young children with behavioral inhibition: (a) reactivity in infancy to novel objects (mobiles); (b) response to unfamiliar objects (a toy robot) in the toddler period; (c) play with unfamiliar same-age peers during preschool age.
Figure 8.2 Assessment of error monitoring using the Erikson Flanker Task (Eriksen & Eriksen, 1974). The subject's task is to press a button indicating the direction of an arrow in the center of the computer screen. That arrow can be “flanked” by arrows in the same direction or in different directions. During the task, brain electrical activity is recorded and synchronized to the subject's button press. On trials where the subject makes an error an event-related potential (ERP) is generated, called the error-related negativity (ERN).
Chapter 9: Neurobiological perspectives on developmental psychopathology
Figure 9.1 The radial unit model of Rakic (1988). Radial glial fibers span from the ventricular zone (VZ) to the cortical plate (CP) via a number of regions: the intermediate zone (IZ) and the subplate zone (SP). RG indicates a radial glial fiber, and MN a migrating neuron. Each MN traverses the IZ and SP zones that contain waiting terminals from the thalamic radiation (TR) and corticocortico (CC) afferents. As described in the text, after entering the cortical plate, the neurons migrate past their predecessors to the marginal zone (MZ).
Figure 9.2 An approximate timeline for some of the most important changes in human brain development.
Chapter 10: Systems neuroscience
Figure 10.1 Relationships among constructs targeted in systems neuroscience. The upper left-hand corner depicts molecular-genetic targets in DNA, as they relate to neuron function, depicted toward the right. Individual neuron function can be related to the functions of neural circuits, composed of collections of neurons. This also is depicted in the Figure Finally, these neural circuits can be studied through imaging, in structures that can be assessed in children using brain imaging. With this technique, the functions of the circuit in the child can be related to the functions that children display in their world, as depicted by a frightened child attending school. Finally, it is emphasized how the environment interacts with each level of this multitiered system, extending from the classroom through the molecular-genetic targets displayed in the upper left-hand corner of the figure.
Figure 10.2 Research on cognitive control. (a) The flanker task is displayed on a screen and the corresponding depiction of a child viewing the screen represents brain regions that are engaged when this task is performed in a brain scanner. (b) The error-related negativity (ERN) response, which is recorded from a child's scalp using electroencephalography. (c) Data collected from neurons of a monkey performing a reward task shown in the Figure Over time, individual events with or without a stimulus presented elicit responses that can be plotted in a so-called “raster” diagram. This is shown immediately adjacent to the monkey. These yield characteristic responses in different parts of the cognitive control circuit to instructions, triggers, and food cues, as also is shown in (c).
Figure 10.3 Two aspects of research on anxiety that inform therapeutics. (a) Work on conditioning and extinction, with the left half of the Figure showing a fear conditioning experiment in rodents and the right half showing circuitry that is thought to be engaged in humans, during extinction. This shows the specific connection between the prefrontal cortex and the amygdala. This includes a depiction of the location where D-cycloserine stimulates the NMDA receptor, which may facilitate extinction and clinical response to cognitive behavioral therapy. (b) Work on attention orienting, as occurs when a threat, such as a snake under a log, is encountered. The circuitry engaged during attention orienting also is shown, as is an apparatus that might be used to provide attention retraining and induce changes in this circuitry.
Figure 10.4 Work on aspects of attachment. (a) Two species of voles and associated brain slices depicting differences in the brain chemistry. (b) A task that might be used to engage the mirror neuron system of a child. Using evoked potentials, activity in the medial prefrontal cortex could be mapped, as also shown in (b) in the child's brain activation map.
Chapter 11: Neuroimaging in child psychiatry
Figure 11.1 Structural (a) and functional (b) and MR images.
Figure 11.2 Canonical hemodynamic response.
Figure 11.3 Statistical parameter maps with (a) and without motion correction (b).
Chapter 14: Evaluating interventions
Figure 14.1 An idealized version of the application of the scientific method to evaluation of interventions.
Figure 14.2 Ninety-five percent two-tailed confidence intervals on the effect size comparing T versus C showing the nine possible patterns that might result, where SRD* is the critical effect size.
Chapter 15: What clinicians need to know about statistical issues and methods
Figure 15.1 Funnel plot showing clear evidence of publication bias.
Figure 15.2 Distribution of baseline verbal IQ and diagnostic groups (PDD-NOS = autistic spectrum but not autism).
Figure 15.3 Relationship between baseline verbal IQ and follow-up ADOS score by initial diagnosis (NS = non autism spectrum; PDD-NOS = autistic spectrum but not autism).
Figure 15.4 Notation for structural equation models.
Figure 15.5 An autoregressive model for continuity. Y1–Y4 are observed variables, b1–b3 are regression coefficients, E2–E4 are the residual error terms.
Figure 15.6 A latent variable continuity model. Y1–Y4 are observed variables and E1–E4 are the measurement error terms; F1–F4 are latent variables indicated by the observed variables and D1–D3 are the disturbances or factor residual error terms.
Figure 15.7 Growth curve model with intercept and slope factors or random effects. Y1–Y4 are the observed variables and E1–E4 are the associated error terms. F1 is a latent variable for the random intercept and F2 is the random slope factor.
Figure 15.8 Regression line. Thick black line represents typical fixed effects regression line, the thin black lines represent spread of slopes implied by a random intercept factor (F1) and the dashed lines the spread of slopes implied by a random slope factor (F2).
Figure 15.9 Trajectories of early development in ADOS scores (from Lord
et al.
, 2012); (non spect. = non autism spectrum; new algorithm = 2007 scoring of ADOS).
Figure 15.10 Confounding of the causal relationship of X to Y by U and the instrumental variable R.
Chapter 16: Global psychiatry
Figure 16.1 The burden of mental and behavioral disorders affecting individuals aged 10–14 years in 2010 (in DALYs/100,000 individuals).
Figure 16.2 The 10/90 divide in research into treatment for childhood and adolescence mental health disorders (2001–2010).
Chapter 18: Health economics
Figure 18.1 Health, social service and education resource use: mean cost over three-year follow-up for all children/young people with a disorder.
Note:
Costs can be converted from £ sterling to US$ by dividing the £ Figure by 0.681.
Figure 18.2 Costs in early adulthood from childhood conduct disorder.
Chapter 24: Genetics
Figure 24.1
DNA, Transcription, and Translation
(a) The double helix structure of DNA is shown at the top. The translation of DNA to RNA to protein is diagrammed moving from top to bottom. The majority of human genes consist of multiple “exons”; segments of DNA that contain a series of three-letter nucleotide codes (codons) that specify individual amino acids. These are interspersed among “introns,” which do not specify amino acids. The central dogma is that DNA (a) is transcribed into RNA and then translated into protein. In transcription, introns are spliced out of the gene, leading to the specification of a full-length mRNA that encodes a specific protein. In addition to the “coding portion” of the gene, additional sequence motifs are present in the DNA and remain in the mRNA including a region immediately upstream of a translation start site, known as the 5′ untranslated region (UTR) and a region just beyond the “stop codon” specifying the termination of translation. These regions are known to be involved in the regulation of gene expression. (b) Variations in the genetic code may lead to several classes of amino acid “substitutions.” As the genetic code contains redundancies, some changes in the code of the DNA will not result in an amino acid change (GLY to GLY in the diagram). This is referred to as a “silent” mutation. When a nucleotide change alters one amino acid to a different amino acid, this is known as a “missense” mutation (ARG to HIS in the diagram). When a change in sequence results in the code for an amino acid changing to a termination (or stop) codon, the mutation is referred to as a nonsense mutation. Amino acid abbreviations: V = valine; H/his = histidine; L = leucine; T/tyr = tryrosine; P/pro = proline; E = glutamic acid; K = lysine; Met = methionine; gly = glycine; Ile = isoleucine; arg = arginine; ser = serine.
Figure 24.2
Microarray-based Copy number variation detection
Figure 24.3
Allele Frequency and Effect Size
Chapter 25: Epigenetics and the developmental origins of vulnerability for mental disorders
Figure 25.1 Nucleosome core particle.
Figure 25.2 Chromatin dynamics and gene transcription.
Figure 25.3 Maternal licking and grooming and demethylation of the glucocorticoid receptor gene in the hippocampus of her offspring.
Chapter 27: Resilience: concepts, findings, and clinical implications
Figure 27.1 Effects of maltreatment on liability to depression moderated by the 5HTT gene (based on Caspi
et al.
, 2003).
Chapter 28: Impact of parental psychiatric disorder and physical illness
Figure 28.1 Theoretical model of the intergenerational transmission of psychopathology.
Chapter 29: Child maltreatment
Figure 29.1 Biological/psychological/medical consequences of maltreatment in children and adults exposed to maltreatment in childhood.
Figure 29.2 Family assessment framework triangle.
Chapter 31: Brain disorders and psychopathology
Figure 31.1 Axial T2W MRI brain scan demonstrates marked periventricular white matter injury in an ex-premature baby. There is lateral ventricular dilatation secondary to white matter volume loss in keeping with Periventricular Leukomalacia (PVL).
Figure 31.2 Axial FLAIR MRI in a two year old demonstrate typical findings of tuberous sclerosis: Several cortical/subcortical tubers (black arrows), “white matter radial migration lines” (open arrow) associated with “subependymal nodules” (white arrow) are demonstrated.
Figure 31.3 A simplified representation of organic and psychosocial pathways from brain to behavioral abnormalities.
Figure 31.4 Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009.
Figure 31.5
Rasmussen's encephalitis:
Axial T2 MRI demonstrates atrophy of the left cerebral hemisphere. There is severe loss of white matter (white arrow) associated with damage of the left basal ganglia (black arrow) and thalamus (white arrow). Note significant progression of the disease over 4 years.
Chapter 34: Psychological assessment in the clinical context
Figure 34.1 Child and environmental factors relevant to psychological assessment.
Figure 34.2 A model standardization/normal curve with percentages,
Z
-score and
T
-scores.
Chapter 35: Physical examination and medical investigation
Figure 35.1 Medical assessment of a 16-year-old female with “possible depression.” BUN, blood urea nitrogen; TSH, thyroid-stimulating hormone.
Figure 35.2 Medical assessment of an 8-year-old female with “possible post traumatic stress disorder,” recently removed from an abusive/neglectful home. PT, prothrombin time; PTT, partial thromboplastin time.
Chapter 36: Psychological interventions: overview and critical issues for the field
Figure 36.1 Mean effect sizes found in two broad-based meta-analyses of adult psychotherapy effects (the two bars at the left: Smith & Glass, 1977; Shapiro & Shapiro, 1982), four broad-based meta-analyses of youth psychotherapy effects (the four middle bars: Casey & Berman, 1985; Weisz
et al.
, 1987; Kazdin
et al.
, 1990; Weisz
et al.
, 1995), and two meta-analyses of RCTs comparing evidence-based youth psychotherapies to usual clinical care (the two bars at the right: Weisz
et al.,
2006a, 2013b). The full bar for Kazdin
et al.
(1990) shows the mean effect size for treatment vs. inert control group comparisons; the dashed line shows the mean for treatment vs. active control group comparisons. The full bar for Weisz
et al.
(1995) shows the mean effect size when unweighted least squares analyses were conducted; the dashed line shows the mean for weighted least squares analyses.
Figure 36.2 Effect sizes of individual studies comparing evidence-based youth psychotherapies (EBPs) to usual care. Horizontal bar at 0.29 shows mean effect size across the full study set. Bars below zero show studies in which usual care produced outcomes superior to those of EBPs. Note the number of studies for which usual care showed effects similar to or superior to EBPs.
Chapter 38: Cognitive-behavioral therapy, behavioral therapy, and related treatments in children
Figure 38.1 Three component model: test anxiety.
Chapter 43: Pharmacological, medically-led and related treatments
Figure 43.1 Establishing a new medication.
Chapter 44: Refugee, asylum-seeking and internally displaced children and adolescents
Figure 44.1 Assessment considerations for forcibly displaced children. Some of the factors described apply only at one phase of the migration process, but it is important to remember that most adverse exposures, such as violence and multiple relocation, can be experienced at any stage of migration.
Chapter 46: Mental health and resilience in children and adolescents affected by HIV/AIDS
Figure 46.1 The social ecological model of risk and protection for children affected by HIV/AIDS.
Chapter 51: Autism spectrum disorder
Figure 51.1 The two domains in the DSM-5 1. social-communication and 2. repetitive and restricted patterns of behaviors are shown in the circles. The sub-domains that make up the domains are shown in the squares.
Chapter 52: Disorders of speech, language, and communication
Figure 52.1 Speech, language, and communication and their component skills.
Figure 52.2 Assessment of communication.
Chapter 53: Disorders of reading, mathematical and motor development
Figure 53.1 Causal model of dyslexia showing biological and cognitive levels of explanation.
Figure 53.2 A two-dimensional model of the relationship between dyslexia and language impairment.
Figure 53.3 Diagram outlining the steps in a comprehensive assessment of SLD.
Chapter 55: ADHD and hyperkinetic disorder
Figure 55.1 ADHD pathogenesis: developmental psychopathology schematic showing the way that early and late operating risks act together to determine continuities and discontinuties in disorder paths.
Figure 55.2 Poor response to standard therapy.
Chapter 56: Tic disorders
Figure 56.1 Course of tic severity. (a) Plot of average tic severity in a cohort of 36 individuals from ages 2–18 years. Tics typically have an onset between ages 4 and 6 years, reach their worst between ages 10 and 12 years, and then decline in severity throughout adolescence. In the ARRTS (Annual Rating of Relative Tic Severity), parents rate the tic symptoms of their children on a six-point ordinal scale (absent [0], least severe, mild, moderate, severe, and most severe [6]). (b) Box plot representing age when tic symptoms were at their worst. Age (years) is represented for all 46 subjects with Tourette's syndrome in a prospective longitudinal study (Bloch
et al
., 2006). The mean ± SD worst-ever tic severity score using the Yale Global Tic Severity Scale (0–50) was 31.6 ± 7.7 (range, 15–48) at a mean ± SD age of 10.6 ± 2.6 years (range, 6–19 years).
Figure 56.2 Cortico-striato-thalamo-cortical circuitry in Tourette's syndrome. Red, excitatory glutamatergic neurons; blue, GABAergic inhibitory neurons; green, cholinergic tonically active interneurons (TANs); orange, dopaminergic neurons. Parvalbumin fast-spiking GABAergic interneurons (PVs, parvalbumins) mediate the cortical feed-forward inhibition upon medium spiny neurons (MSNs) of the striatopallidal direct pathway, resulting in inhibition of voluntary movements. Cholinergic TANs enhance the responsiveness of MSNs of the striatonigral indirect pathway, resulting in movement suppression. PVs and TANs are diminished in number in the brains of adults with severe, persistent Tourette's syndrome (see text). The volume of the striatum, particularly the caudate nuclei, is smaller in both children and adults with Tourette's syndrome. Receptors include: M1 and nicotinic (N) cholinergic receptors; D
1
and D
2
dopamine receptors.
Chapter 57: Schizophrenia and psychosis
Figure 57.1 Summary of key gray matter structural changes reported from NIMH EOS sample (Rapoport & Gogtay, 2011). In addition, ventricular enlargement at baseline and slower growth rates of (especially right hemispheric) white matter are also noted. COS: Childhood-onset schizophrenia.
Chapter 60: Anxiety disorders
Figure 60.1 This Figure shows two specific behaviors that have been studied in animals and extended through brain imaging research to children. One of these behaviors involves fear conditioning, when a neutral stimulus acquires the capacity to evoke fear, and extinction, when subsequent learning allows the organism to no longer treat the conditioned stimulus as dangerous. The other behavior involves attention orienting, when a threat in the environment captures attention. Brain imaging research links fear conditioning to a brain circuit involving the amygdala and the ventro-medial portion of the prefrontal cortex (PFC). Similarly, studies of the amygdala and ventro-lateral PFC functions link clinical anxiety to perturbed attention to threat.
Chapter 61: Obsessive compulsive disorder
Figure 61.1 The direct and indirect circuitry thought to underlie the pathogenesis of OCD. GPi, globus pallidus pars interna; GPe, globus pallidus pars externa; SNr, substantia nigra pars reticulata. In the DIRECT pathway (thick arrows), the frontal cortex projects to the caudate and then to the GPi/SN complex which provides the main output of the basal ganglia. This in turn projects to the thalamus and finally back to the frontal cortex. The pathway has two excitatory and two inhibitory projections and thus is a net positive feedback loop. This circuit is balanced by the INDIRECT pathway (in thin arrows) which has a net inhibitory effect. This differs in its projection from the caudate to the GPe/SN complex (which also receives direct frontal input) before relaying onto the output station of the basal ganglia (the GPi/SNr complex). Interactions with the limbic system occur at several points and have been increasingly recognized in view of deficits in emotional processing and the anxiety prominent in OCD.
Chapter 62: Bipolar disorder in childhood
Figure 62.1 Psychopharmacology algorithm. *First-line agents based upon present data in childhood-onset BD.
Chapter 64: Suicidal behavior and self-harm
Figure 64.1 Pathway model illustrating key risk factors for adolescent self-harm and suicide.
Figure 64.2 Prevalence of mental disorders in children and adolescents attending general hospitals following self-harm.
Chapter 65: Oppositional and conduct disorders
Figure 65.1 Subtypes of antisocial behavior by longitudinal course (data synthesis from several longitudinal studies).
Chapter 66: Substance-related and addictive disorders
Figure 66.1 Schematic illustration of dysphoria induced by repeated intoxication-withdrawal cyles (cf., Koob & Volkow, 2010). Each intoxication leads to a subjective “high”, with enhanced response to reward in dopaminergic structures. Each acute withdrawal event results in subjective dysphoria with reduced response to reward. Frequent cycle repetitions gradually suppress subjective “highs”, deepening dysphoria. Increasingly, the drug is used to escape dysphoria and achieve normal mood. During abstinence, mood slowly recovers.
Source
: Reproduced by permission from Crowley
et al
. (2010).
Chapter 68: Developmental risk for psychopathy
Figure 68.1 The main finding from Viding et al. (2005), showing the degree to which a group difference in conduct problem scores between typically developing children and 1) children with conduct problems with high levels of callous-unemotional traits (CP/HCU) and 2) children with conduct problems with low levels of callous-unemotional traits (CP/LCU) is due to additive genetic (A), shared environmental (C) and non-shared environmental (E) influences.
Figure 68.2 Neural circuitry involved in emotion, reward and empathic processing
Chapter 70: Sleep interventions: a developmental perspective
Figure 70.1 Targets for improving sleep in children and adolescents.
Chapter 72: Somatoform and related disorders
Figure 72.1 The spectrum of functional somatic symptoms and somatoform and related disorders.
Figure 72.2 Explanatory model. Explanatory model for the development and maintenance of functional somatic symptoms and somatoform and related disorders.
Figure 72.3 Stepped care model for the management of functional somatic symptoms and somatoform and related disorders.
Chapter 2: Diagnosis, diagnostic formulations, and classification
Table 2.1 Possible validating criteria for different disorders.
Table 2.2 Level of validating evidence for a range of disorders.
Chapter 4: Conceptual issues and empirical challenges in the disruptive behavior disorders
Table 4.1 Well-replicated findings for disruptive behavior problems.
Chapter 5: Emotion, emotion regulation and emotional disorders: conceptual issues for clinicians and neuroscientists
Table 5.1 Irritability compared to other common symptoms of child psychiatric disorders.
Chapter 6: Attachment: normal development, individual differences, and associations with experience
Table 6.1 Strange situation overview.
Table 6.2 Overview of strange situation classifications.
Chapter 7: Infant/early years mental health
Table 7.1 Examples of parental reports used in assessing infants.
Table 7.2 Examples of methods for assessing parent–infant interaction and relationship.
Chapter 12: Using natural experiments and animal models to study causal hypotheses in relation to child mental health problems
Table 12.1 Key terms and their conceptual meaning.
Chapter 13: Using epidemiology to plan, organize, and evaluate services for children and adolescents with mental health problems
Table 13.1 Rates of service use for mental health problems in community-based studies among (1) children with impairing psychopathology as defined by individual studies and (2) the population.
Chapter 15: What clinicians need to know about statistical issues and methods
Table 15.1 Summary statistics for the repeated measures of childhood ability (Osbourne & Suddick, 1972).
Chapter 16: Global psychiatry
Table 16.1 Studies on the global prevalence of child and adolescent mental disorders in LMIC.
Table 16.2 Abridged recommendations for child and adolescent mental health conditions (CAMH 1–13).
Chapter 25: Epigenetics and the developmental origins of vulnerability for mental disorders
Table 25.1 Maternal postnatal licking and grooming (LG), offspring phenotype and reversal of maternal effects through cross-fostering or neonatal handling.
Chapter 29: Child maltreatment
Table 29.1 NICE guidelines on recognition of child maltreatment.
Chapter 30: Child sexual abuse
Table 30.1 Prevalence rates of sexual abuse.
Table 30.2 Percentage contact child sexual abuse experienced by age.
Table 30.3 Percentage overall child sexual abuse experienced by age.
Table 30.4 Adulthood effects of CSA.
Chapter 32: Clinical assessment and diagnostic formulation
Table 32.1 Basic elements in child and adolescent psychiatric assessments.
Chapter 33: Use of structured interviews, rating scales, and observational methods in clinical settings
Table 33.1 Structured diagnostic interviews.
Table 33.2 Measures focusing on anxiety and depression.
Table 33.3 Measures focusing on behavioral and disruptive symptoms.
Chapter 34: Psychological assessment in the clinical context
Table 34.1 Age ranges and derived standarization scores of widely used IQ and developmental assessments.
Chapter 35: Physical examination and medical investigation
Table 35.1 Differential diagnosis of delirium/psychosis.
Chapter 36: Psychological interventions: overview and critical issues for the field
Table 36.1 Evidence-based youth psychotherapies
a, b
.
Table 36.2 Percentage of groups in youth psychotherapy outcome studies that employed clinically representative youths, therapists, and treatment settings.
Chapter 37: Parenting programs
Table 37.1 Characteristics of some widely used programs.
Table 37.2 Content of a typical social learning program.
Table 37.3 Pros and cons of delivering parenting programs in individual versus group format.
Chapter 42: School-based mental health interventions
Table 42.1 Evidence of effectiveness of school-based interventions.
Chapter 43: Pharmacological, medically-led and related treatments
Table 43.1 Considerations specific to individual antihyperkinetic drugs.
Table 43.3 Antidepressants.
Table 43.2 Considerations specific to individual second-generation antipsychotics (SGA).
Chapter 44: Refugee, asylum-seeking and internally displaced children and adolescents
Table 44.1 Some illustrative studies of the prevalence and risk factors for psychiatric disorder in forcibly displaced children and young people.
Table 44.2 Examples of randomized controlled trials.
Chapter 45: Pediatric consultation and psychiatric aspects of somatic disease
Table 45.1 Steps to the consultation.
Table 45.2 Conditions commonly associated with delirium.
Chapter 48: Assessment and treatment in nonspecialist community health care settings
Table 48.1 Relative merits of primary health care versus school interventions for mental health problems.
Table 48.2 Child & adolescent psychiatric problems appropriate for direct primary health care intervention.
Chapter 49: Forensic psychiatry
Table 49.1 Roles for forensic child and adolescent mental health services
(Mental disorder includes mental illnesses, neurodevelopmental disorders, and substance misuse).
Table 49.2 Types of risks.
Table 49.3 A public health model for youth offending.
Chapter 50: Provision of intensive treatment: intensive outreach, day units, and in-patient units
Table 50.1 Defining characteristics of specific community intensive services and evidence to support effectiveness.
Chapter 51: Autism spectrum disorder
Table 51.1 Differential diagnosis.
Table 51.2 Coexisting conditions.
Chapter 52: Disorders of speech, language, and communication
Table 52.1 A sample of formal language assessments in common use.
Chapter 54: Intellectual disability
Table 54.1 Behavioral phenotypes.
Chapter 55: ADHD and hyperkinetic disorder
Table 55.1 Management of adverse effects of medication.
Chapter 57: Schizophrenia and psychosis
Table 57.1 Comparison of early-onset and adult-onset schizophrenia.
Table 57.2 Physical investigations in child and adolescent-onset psychoses.
Chapter 58: Disorders of attachment and social engagement related to deprivation
Table 58.1 Development of attachment in early childhood.
Chapter 60: Anxiety disorders
Table 60.1 Prevalence (%) of anxiety disorders in children, adolescents, and adults followed prospectively.
Table 60.2 Anxiety in children as a function of parental psychopathology.
Chapter 61: Obsessive compulsive disorder
Table 61.1 Community studies of OCD prevalence in children and adolescents.
Table 61.2 Presenting symptoms in 70 consecutive children and adolescents with primary obsessive compulsive disorder.
Table 61.3 Controlled studies of medication in the treatment of pediatric OCD.
Chapter 62: Bipolar disorder in childhood
Table 62.1 Severe mood dysregulation (SMD) diagnostic criteria.
Chapter 63: Depressive disorders in childhood and adolescence
Table 63.1 Levels of severity of depression.
Table 63.2 Summary of some of the more recent clinical trials in adolescent depression.
Table 63.3 Initial approach to the depressed child or adolescent.
Table 63.4 Psychoeducation: key points for parents and patients.
Chapter 64: Suicidal behavior and self-harm
Table 64.1 Male and female suicide rates for children, adolescents, and young adults for selected countries (World Health Organization, 2014).
Table 64.2 Areas to cover during psychosocial assessment of adolescents who have self-harmed.
Table 64.3 Major components of the Therapeutic Assessment.
Chapter 65: Oppositional and conduct disorders
Table 65.1 Adult functioning of children who had ODD/CD.
Table 65.2 Factors predicting poor outcome.
Chapter 66: Substance-related and addictive disorders
Table 66.1 Range of substance use prevalence (percent of 16 Year-Olds), 36 European countries and USA
aa
.
Table 66.2 Evidence base supporting psychosocial treatments of adolescent substance abuse.
Chapter 67: Disorders of personality
Table 67.1 The characteristics of 10 key personality disorders.
Chapter 70: Sleep interventions: a developmental perspective
Table 70.1 Assessment of sleep problems: domains to include.
Table 70.2 Stimulus control and sleep restriction: intervention and rationale.
Chapter 71: Feeding and eating disorders
Table 71.1 Differential and common comorbid diagnoses.
Table 71.2 Main components of comprehensive biopsychosocial assessment and relationship to risk.
Table 71.3 Screening and assessment measures for child and adolescent feeding and eating disorders.
Table 71.4 Common indications for admission/increased intensity of treatment.
Chapter 72: Somatoform and related disorders
Table 72.1 Different terms and diagnostic labels used for somatoform and related disorders according to medical specialty.
Table 72.2 Selected population-based studies that have assessed different types of somatic complaints/functional somatic symptoms (FSS).
Table 72.3 Selected measures for assessment of functional somatic symptoms and somatoform and related disorders.
Table 72.4 General principles for helping engagement in assessment and treatment (Goldberg
et al
., 1989).
Table 72.5 General principles for the treatment of somatoform and related disorders.
